Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Recruiting × NSCLC × Docetaxel × Clear all

Phase

Status

Unknown 3 Suspended 1 Recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Carcinoma, Non-Small-Cell Lung 31 Breast Neoplasms 22 Prostatic Neoplasms 19 Stomach Neoplasms 13 Squamous Cell Carcinoma of Head and Neck 10 Neoplasms 10 Triple Negative Breast Neoplasms 9 Lung Neoplasms 8 Urinary Bladder Neoplasms 7 Head and Neck Neoplasms 7 Neoplasm Metastasis 6 Nasopharyngeal Carcinoma 5 Carcinoma, Squamous Cell 5 Adenocarcinoma 5 Non-Muscle Invasive Bladder Neoplasms 4 Carcinoma, Transitional Cell 4 Sarcoma 3 Recurrence 3 Prostatic Neoplasms, Castration-Resistant 3 Ovarian Neoplasms 3 Oropharyngeal Neoplasms 3 HER2-positive Breast Cancer 3 Endometrial Neoplasms 3 Anatomic Stage I Breast Cancer AJCC v8 3 Advanced Solid Tumors 3 Vaccinia 2 Salivary Gland Neoplasms 2 Parkinson Disease 4, Autosomal Dominant Lewy Body 2 Metastatic Castration-resistant Prostate Cancer 2 Metastatic Castration-Resistant Prostate Cancer 2

Interventions

Drug Therapy 4 Radiotherapy 3 osimertinib 2 aflutinib 2 Radiosurgery 2 Pemetrexed 2 Carboplatin 2 trilaciclib 1 toripalimab 1 tislelizumab 1 sugemalimab 1 spartalizumab 1 sintilimab 1 pembrolizumab 1 cemiplimab 1 Vinorelbine 1 Platinum 1 Paclitaxel 1 Immune Checkpoint Inhibitors 1 Gemcitabine 1 Docetaxel 1 Cisplatin 1 Chemotherapy, Adjuvant 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT06576635 2026-01-20

LUNG-05

University of Illinois at Chicago

Phase NA Recruiting

NSCLC

Data powered by HemOnc (CC BY 4.0) Colophon ⚡